These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
299 related articles for article (PubMed ID: 17606691)
21. Antiviral activities of tragacanthin polysaccharides on Punta Toro virus infections in mice. Smee DF; Sidwell RW; Huffman JH; Huggins JW; Kende M; Verbiscar AJ Chemotherapy; 1996; 42(4):286-93. PubMed ID: 8804797 [TBL] [Abstract][Full Text] [Related]
22. T-705 (Favipiravir) suppresses tumor necrosis factor α production in response to influenza virus infection: A beneficial feature of T-705 as an anti-influenza drug. Tanaka T; Kamiyama T; Daikoku T; Takahashi K; Nomura N; Kurokawa M; Shiraki K Acta Virol; 2017; 61(1):48-55. PubMed ID: 28105854 [TBL] [Abstract][Full Text] [Related]
23. Activity of T-1106 in a hamster model of yellow Fever virus infection. Julander JG; Furuta Y; Shafer K; Sidwell RW Antimicrob Agents Chemother; 2007 Jun; 51(6):1962-6. PubMed ID: 17420215 [TBL] [Abstract][Full Text] [Related]
24. Selective inhibition of arthropod-borne and arenaviruses in vitro by 3'-fluoro-3'-deoxyadenosine. Smee DF; Morris JL; Barnard DL; Van Aerschot A Antiviral Res; 1992 Jun; 18(2):151-62. PubMed ID: 1365816 [TBL] [Abstract][Full Text] [Related]
25. In vitro and in vivo activities of T-705 and oseltamivir against influenza virus. Takahashi K; Furuta Y; Fukuda Y; Kuno M; Kamiyama T; Kozaki K; Nomura N; Egawa H; Minami S; Shiraki K Antivir Chem Chemother; 2003 Sep; 14(5):235-41. PubMed ID: 14694986 [TBL] [Abstract][Full Text] [Related]
26. A biotechnological product and its potential as a new immunomodulator for treatment of animal phlebovirus infection: Punta Toro virus. Durán N; Gowen BB; Costa FT; Justo GZ; Brocchi M; Nunes OS; Nunes IS Antiviral Res; 2009 Aug; 83(2):143-7. PubMed ID: 19393266 [TBL] [Abstract][Full Text] [Related]
27. Genistein, a general kinase inhibitor, as a potential antiviral for arenaviral hemorrhagic fever as described in the Pirital virus-Syrian golden hamster model. Vela EM; Knostman KA; Mott JM; Warren RL; Garver JN; Vela LJ; Stammen RL Antiviral Res; 2010 Sep; 87(3):318-28. PubMed ID: 20600333 [TBL] [Abstract][Full Text] [Related]
28. Synthesis and antiviral evaluation of N-carboxamidine-substituted analogues of 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamidine hydrochloride. Gabrielsen B; Phelan MJ; Barthel-Rosa L; See C; Huggins JW; Kefauver DF; Monath TP; Ussery MA; Chmurny GN; Schubert EM J Med Chem; 1992 Aug; 35(17):3231-8. PubMed ID: 1507208 [TBL] [Abstract][Full Text] [Related]
29. Coadministration of LHF-535 and favipiravir protects against experimental Junín virus infection and disease. Westover JB; Bailey KW; Wasson SR; Boardman KM; Lustig KH; Amberg SM; Gowen BB Antiviral Res; 2024 Sep; 229():105952. PubMed ID: 38945484 [TBL] [Abstract][Full Text] [Related]
30. Optimizing T-705 (favipiravir) treatment of severe influenza B virus infection in the immunocompromised mouse model. Pascua PNQ; Marathe BM; Vogel P; Webby RJ; Govorkova EA J Antimicrob Chemother; 2019 May; 74(5):1333-1341. PubMed ID: 30715325 [TBL] [Abstract][Full Text] [Related]
31. In vitro and in vivo activities of anti-influenza virus compound T-705. Furuta Y; Takahashi K; Fukuda Y; Kuno M; Kamiyama T; Kozaki K; Nomura N; Egawa H; Minami S; Watanabe Y; Narita H; Shiraki K Antimicrob Agents Chemother; 2002 Apr; 46(4):977-81. PubMed ID: 11897578 [TBL] [Abstract][Full Text] [Related]
32. Alterations in favipiravir (T-705) pharmacokinetics and biodistribution in a hamster model of viral hemorrhagic fever. Gowen BB; Sefing EJ; Westover JB; Smee DF; Hagloch J; Furuta Y; Hall JO Antiviral Res; 2015 Sep; 121():132-7. PubMed ID: 26186980 [TBL] [Abstract][Full Text] [Related]